Copyright
©The Author(s) 2022.
World J Hepatol. Nov 27, 2022; 14(11): 1964-1976
Published online Nov 27, 2022. doi: 10.4254/wjh.v14.i11.1964
Published online Nov 27, 2022. doi: 10.4254/wjh.v14.i11.1964
Parameter | Stable cirrhosis (n = 20) | Acute decompensation (n = 200) | P value |
Age (yr), mean ± SD | 51.35 ± 12.68 | 57.29 ± 11.56 | 0.056 |
Male gender, n (%) | 15 (75.0) | 143 (71.5) | 0.740 |
Etiology of cirrhosis1, n (%) | |||
Alcohol | 12 (60.0) | 106 (53.0) | 0.549 |
Hepatitis C | 6 (30.0) | 58 (29.0) | 0.925 |
Hepatitis B | 3 (15.0) | 10 (5.0) | 0.102 |
Cryptogenicautoimmune | 2 (10.0) | 8 (4.0) | 0.229 |
Autoimmune | 0 (0.0) | 11 (5.5) | 0.605 |
NASH | 0 (0.0) | 25 (12.6) | 0.139 |
Other2 | 2 (10.0) | 11 (5.5) | 0.335 |
Active alcoholism, n (%) | 0 (0.0) | 34 (17.0) | 0.049 |
Prior decompensation, n (%) | 15 (75.0) | 173 (86.5) | 0.182 |
Laboratory data | |||
Leukocyte count (×109), median | 4.96 | 6.54 | 0.008 |
Sodium (mEq/L), mean ± SD | 138.05 ± 1.50 | 136.24 ± 5.21 | < 0.001 |
Creatinine (mg/dL), median | 0.8 | 1.11 | < 0.001 |
INR, median | 1.15 | 1.46 | < 0.001 |
Albumin (g/dL), mean ± SD | 3.54 ± 0.34 | 2.63 ± 0.68 | < 0.001 |
CRP (mg/L), median | 3.0 | 18.2 | < 0.001 |
Total bilirubin (mg/dL), median | 1.10 | 2.20 | < 0.001 |
Calprotectin (ng/dL), median | 396.5 | 477.2 | 0.127 |
Child-Pugh score, mean ± SD | 6.40 ± 1.60 | 9.24 ± 1.92 | < 0.001 |
Child-Pugh A, n (%) | 13 (65.0) | 12 (6.0) | < 0.001 |
Child-Pugh B, n (%) | 6 (30.0) | 97 (48.5) | 0.114 |
Child-Pugh C, n (%) | 1 (5.0) | 91 (45.5) | < 0.001 |
MELD score, mean ± SD | 9.4 ± 1.8 | 17.6 ± 7.0 | < 0.001 |
Complication at evaluation, n (%) | |||
Ascites | 2 (10.0) | 125 (62.5) | < 0.001 |
Hepatic encephalopathy | 3 (15.0) | 99 (48.5) | < 0.001 |
Gastrointestinal bleeding | - | 66 (33.0) | |
Bacterial infection | - | 70 (35.0) | |
Alcoholic hepatitis | - | 11 (5.5) | |
CLIF-SOFA, median | - | 7.00 | |
ACLF, n (%) | - | 56 (28.0) | |
ACLF grade, n (%) | |||
Grade 1 | - | 37 (18.5) | |
Grade 2 | - | 11 (5.5) | |
Grade 3 | - | 8 (4.0) |
- Citation: Matiollo C, Rateke ECM, Moura EQA, Andrigueti M, Augustinho FC, Zocche TL, Silva TE, Gomes LO, Farias MR, Narciso-Schiavon JL, Schiavon LL. Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis. World J Hepatol 2022; 14(11): 1964-1976
- URL: https://www.wjgnet.com/1948-5182/full/v14/i11/1964.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i11.1964